Anti-Tau (nitrosyl Y29) antibody [EPR27841-79] - BSA and Azide free
- Recombinant
- RabMAb
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal TAU nitrosyl Y29 antibody. Carrier free. Suitable for WB, I-ELISA, Dot and reacts with Transfected cell lysate - Human, Synthetic peptide - Human samples.
View Alternative Names
MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau
- I-ELISA
Supplier Data
Indirect ELISA - Anti-Tau (nitrosyl Y29) antibody [EPR27841-79] - BSA and Azide free (AB315892)
This data was developed using ab315891, the same antibody clone in a different buffer formulation.
Indirect ELISA analysis of ab315891 at 1000-0 ng/ml. The Secondary antibody used was Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG (H+L) at 1 : 2500 dilution.
Antigen : Tau (nitrosylated Y29) peptide a,Tau (nitrosylated Y29) peptide b,Tau non-nitrosylated Y29 peptide c,Tau (phospho Y29) peptide d,Tau (nitrosylated Y18) peptide e,Tau (nitrosylated Y18) peptide f.
Antigen concentration : 1000 ng/ml
- WB
Supplier Data
Western blot - Anti-Tau (nitrosyl Y29) antibody [EPR27841-79] - BSA and Azide free (AB315892)
This data was developed using ab315891, the same antibody clone in a different buffer formulation.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
In Western blot, Anti-Tau antibody - Total protein control (ab254256) staining at 1/1000 dilution.
In Western blot, Anti-6X His tag® antibody [EPR20547] - ChIP Grade (ab213204) staining at 1/5000 dilution.
All lanes:
Western blot - Anti-Tau (nitrosyl Y29) antibody [EPR27841-79] (<a href='/en-us/products/primary-antibodies/tau-nitrosyl-y29-antibody-epr27841-79-ab315891'>ab315891</a>) at 1/1000 dilution
Lane 1:
Untreated 293T cells transfected with an empty vector containing a His-tag, whole cell lysate at 20 µg
Lane 2:
293T cells transfected with an empty vector containing a His-tag were treated with 3mM peroxynitrite for 1 hour, whole cell lysate at 20 µg
Lane 3:
Untreated 293T cells transfected with a human Tau 2N4R expression vector containing a His-tag, whole cell lysate at 20 µg
Lane 4:
293T cells transfected with a human Tau 2N4R expression vector containing a His-tag were treated with 3mM peroxynitrite for 1 hour, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 20-75 kDa,36 kDa
false
Exposure time: 180s
- Dot
Supplier Data
Dot Blot - Anti-Tau (nitrosyl Y29) antibody [EPR27841-79] - BSA and Azide free (AB315892)
This data was developed using ab315891, the same antibody clone in a different buffer formulation.
Dot blot analysis of Tau (nitrosyl Y29) using ab315891 at 1 : 1000 (0.518 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 100,000 dilution.
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Dot Blot - Anti-Tau (nitrosyl Y29) antibody [EPR27841-79] (<a href='/en-us/products/primary-antibodies/tau-nitrosyl-y29-antibody-epr27841-79-ab315891'>ab315891</a>) at 1/1000 dilution
Lane 1:
Tau (nitrosylated Y29) peptide a
Lane 2:
Tau (nitrosylated Y29) peptide b
Lane 3:
Tau non-nitrosylated Y29 peptide c
Lane 4:
Tau (phospho Y29) peptide d
Lane 5:
Tau (nitrosylated Y18) peptide e
Lane 6:
Tau (nitrosylated Y18) peptide f
Secondary
All lanes:
Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
false
Exposure time: 180s
Related conjugates and formulations (1)
-
Anti-Tau (nitrosyl Y29) antibody [EPR27841-79]
Reactivity data
Product details
ab315892 is the carrier-free version of ab315891.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Tau is involved in the assembly and stabilization of microtubules essential for maintaining neuronal structure. It interacts with microtubule-binding domains (MBD) to bind and bundle microtubules facilitating intracellular transport. Tau forms a part of the neuronal cytoskeleton complex working closely with other cytoskeletal proteins to preserve the proper axonal transport and function. Abnormally phosphorylated Tau often termed phospho-Tau disrupts this complex affecting microtubule stability.
Pathways
Tau has critical involvement in several signaling cascades such as the microtubule-binding and transport pathways. Glycogen synthase kinase 3 beta (GSK3β) and cyclin-dependent kinase 5 (CDK5) frequently phosphorylate Tau controlling its interaction with microtubules. Phosphorylated Tau accumulates leading to the formation of neurofibrillary tangles often observed in neurodegenerative conditions. Additionally Tau interacts with GAPDH impacting cellular energy regulation through potential pathway cross-talk involving oxidative stress responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com